Inventors:
David A. Betebenner - Libertyville IL, US
David A. DeGoey - Salem WI, US
Clarence J. Maring - Palatine IL, US
Allan C. Krueger - Gurnee IL, US
Nobuhiko Iwasaki - Buffalo Grove IL, US
Todd W. Rockway - Grayslake IL, US
Curt S. Cooper - Vernon Hills IL, US
David D. Anderson - Kenosha WI, US
Pamela L. Donner - Mundelein IL, US
Brian E. Green - Wonder Lake IL, US
Dale J. Kempf - Libertyville IL, US
Dachun Liu - Waukegan IL, US
Keith F. McDaniel - Wauconda IL, US
Darold L. Madigan - Elk Grove Village IL, US
Christopher E. Motter - Oak Creek WI, US
John K. Pratt - Kenosha WI, US
Jason P. Shanley - Chicago IL, US
Michael D. Tufano - Chicago IL, US
Rolf Wagner - Antioch IL, US
Rong Zhang - Niskayuna NY, US
Akhteruzzaman Molla - Gurnee IL, US
Hongmei Mo - Foster City CA, US
Sherie V L. Masse - Kenosha WI, US
Robert J. Carrick - Pleasant Prairie WI, US
Wenping He - Libertyville IL, US
Liangjun Lu - Kildeer IL, US
David J. Grampovnik - Waukegan IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D 471/04
A01N 31/519
A61P 31/12
US Classification:
51426411, 544279, 5142641
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.